
A novel technique combining blunt separation and uncrosslinked hyaluronic acid compound solution shows promise in treating tear trough deformities (TTD) in Asians. In a study of 26 Chinese patients, the treatment significantly reduced tear trough rating scale (TTRS) scores immediately and up to one-year post-treatment. Mild side effects like pain, erythema, and swelling were reported, with only three cases of postinjection bruising lasting 6–7 days. No recurrent cases occurred, indicating the approach is safe and effective, offering a potential solution for TTD with high patient satisfaction.
Like
Save
Share